Journal of Medical Economics is a MEDLINE-indexed, international journal publishing rigorously peer-reviewed review articles and original papers in the pharmacoeconomics and healthcare research community.

Journal of Medical Economics aims to help translate research advances into patient care and lead in transparency/disclosure. The journal publishes high-quality economic assessments of novel therapeutic and device interventions for an international audience.

Journal of Medical Economics also specializes in the publication of studies that determine the effectiveness of medical treatment, involving measurements of therapeutic and/or preventative outcomes. Methods employed in the studies commonly involve sets of patients with comparable clinical characteristics and include measurements of mortality, morbidity and patient-reported outcomes (including the patient’s quality of life, functional status and satisfaction with healthcare).

Articles focus on the following key areas:

    Economic analyses (in the form of cost minimization, cost effectiveness, cost utility, cost benefits, cost consequence, cost of illness, burden of disease)
    Health economics methodology
    Discussions on policy issues
    Resource utilization studies
    Disease management
    Modelling studies
    Meta-analyses of randomized controlled trials, outcomes and clinical trials data

All manuscripts submitted to the journal are peer-reviewed in a single-anonymized fashion. 



*Please note that Journal of Medical Economic converted to a fully Open Access journal beginning with Volume 24 (2021). The 1998-2020 volumes will be free to access from 1 January 2021.

Taylor & Francis Medical Editor: Sarah Webster 

Professor Kenneth L. Lee, Monash University, Malaysia, Editor-in-Chief 

Professor Ivo Abraham, University of Arizona, USA, Deputy Editor-in-Chief 

Editorial Board 

Dr Lieven Annemans, Ghent University, Belgium 
Dr Ameet Bakhai, Barnet General Hospital, UK 
Dr Jonathan Belsey, JB Medical, UK 
Dr Christopher Blanchette, UNC Charlotte, USA 
Dr Oleg Borisenko, RSPOR, Moscow, Russia 
Professor Nick Bosanquet, Imperial College London, UK 
Dr João Carapinha, Carapinha & Company, USA 
Dr Nathorn Chaiyakunapruk, Monash University, Malaysia 
Dr Livio Garattini, Mario Negri Institute for Pharmacological Research, Italy 
Professor Ron Goeree, McMaster University, Canada 
Mr Paul E. Greenberg, Analysis Group Economics, USA 
Mr Michael Halpern, RTI International, USA 
Dr Alan Haycox, University of Liverpool, UK 
Dr Mickaël Hiligsmann, Maastricht University, The Netherlands 
Professor Shanlian Hu, Fudan University, China 
Professor Michael Hyland, University of Plymouth, UK 
Professor Mihajlo Jakovljevic, University of Kragujevac, Serbia 
Dr Vijay Joish, Bayer Healthcare Pharmaceuticals, USA 
Professor Isao Kamae, Keio University, Japan 
Dr Paul Kind, University of Leeds, UK 
Dr Vivian Lee, Chinese University of Hong Kong, Hong Kong 
Dr Won Chan Lee, Proteus Digital Health, USA 
Professor Shu Chuen Li, University of Newcastle, Australia 
Professor Dr Stephen P. McKenna, Galen Research, UK 
Dr Roger Lee Mendoza, California State University, USA 
Dr Matthew Murawski, Purdue University, USA 
Dr Chris Pashos, Takeda Pharmaceuticals, USA 
Professor Paul Scuffham, Griffith University, Australia 
Dr Fadia T. Shaya, University of Maryland, USA 
Professor Dean G. Smith, University of Michigan, USA 
Professor Sean D. Sullivan, University of Washington, USA 
Mr Adrian Towse, Office for Health Economics, UK 
Dr David Wu, Monash University School of Medicine, Malaysia 
Dr Bong-Min Yang, Seoul National University, Republic of Korea 
Dr York Francis Zöllner, Hamburg University of Applied Sciences, Germany